| Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer (NCT05388773) | Heath Skinner | 2022-07-20 |
| A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) (NCT05307939) | Memorial Sloan Kettering Cancer Center | 2022-03-24 |
| Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer (NCT05698667) | Rigshospitalet, Denmark | 2021-10-01 |
| Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers (NCT05055206) | University Health Network, Toronto | 2021-09-13 |
| Adaptive RadioTherapy for OroPharynx Cancer (NCT04901234) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-07-30 |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy (NCT05337631) | University Hospital Freiburg | 2021-06-01 |
| Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx (NCT04667585) | Duke University | 2021-04-12 |
| Bitter Taste Receptors in Oropharynx Cancer (NCT05211427) | Thomas Hummel | 2021-03-23 |
| Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110) (NCT04609280) | University of Maryland, Baltimore | 2021-03-01 |
| Circulating Biomarkers in Oropharyngeal Cancers (NCT05904327) | Region Örebro County | 2020-12-01 |
| Collagen Matrix in Oral Cancer Surgery (NCT07337122) | SAYAH Charline | 2020-11-16 |
| Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer (NCT04444869) | University of Missouri-Columbia | 2020-09-28 |
| QUantitative Assessment of Swallowing After Radiation (QUASAR) (NCT04359199) | Loren Mell, MD | 2020-09-01 |
| Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors (NCT04301011) | Turnstone Biologics, Corp. | 2020-06-02 |
| Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer (NCT04178174) | Centre hospitalier de l'Université de Montréal (CHUM) | 2020-02-23 |
| Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients (NCT04001413) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-09-17 |
| Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth (NCT03874572) | Rigshospitalet, Denmark | 2019-03-18 |
| Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma (NCT04124198) | Christian von Buchwald | 2019-03-01 |
| Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer (NCT03435471) | University of Miami | 2018-09-17 |
| Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer. (NCT04277858) | Nader Sadeghi | 2018-08-14 |
| Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer (NCT03416153) | University of Michigan Rogel Cancer Center | 2018-05-21 |
| PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients (NCT03342378) | University of Wisconsin, Madison | 2018-05-03 |
| Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer (NCT03383094) | Loren Mell, MD | 2018-03-15 |
| Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx (NCT03418792) | UNC Lineberger Comprehensive Cancer Center | 2018-03-08 |
| Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma (NCT03174275) | UNC Lineberger Comprehensive Cancer Center | 2017-12-19 |
| New Modalities for Detection of Oropharyngeal Cancer (NCT03226613) | Vanderbilt University Medical Center | 2017-08-15 |
| Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer (NCT03269344) | Henry Ford Health System | 2017-06-05 |
| Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma (NCT03418909) | Rigshospitalet, Denmark | 2017-04-01 |
| Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03082534) | University of California, San Diego | 2017-03-28 |
| Adaptive Radiotherapy for Head and Neck Cancer (NCT03096808) | Memorial Sloan Kettering Cancer Center | 2017-03-15 |
| Cell-free Tumor DNA in Head and Neck Cancer Patients (NCT03942380) | Christian von Buchwald | 2017-02-01 |
| Physiological Flow of Liquids in Head and Neck Cancer Patients: A Pilot Study (NCT04112940) | University Health Network, Toronto | 2016-12-19 |
| CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas (NCT02981862) | Institut de Cancérologie de Lorraine | 2016-12-19 |
| Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer (NCT02908477) | Mayo Clinic | 2016-10-03 |
| Pembrolizumab in Combination With CRT for LA-SCCHN (NCT02586207) | Sanford Health | 2015-11-01 |
| Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (ARTOME) (NCT05025618) | Center Eugene Marquis | 2013-07-05 |
| Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (NCT01874587) | Center Eugene Marquis | 2013-07-01 |
| Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study. (NCT01173692) | M.D. Anderson Cancer Center | 2010-07-22 |
| TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer (NCT01108042) | Orlando Guntinas-Lichius, Prof. Dr. med. | 2009-11-01 |
| OraTest in Combination With Visual Examination and Visual Examination Alone (NCT00537199) | M.D. Anderson Cancer Center | 2006-11-01 |
| Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC (NCT00232960) | Gustave Roussy, Cancer Campus, Grand Paris | 2005-10-01 |
| IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC (NCT00158678) | Groupe Oncologie Radiotherapie Tete et Cou | 2005-09-27 |
| Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC (NCT00158652) | Groupe Oncologie Radiotherapie Tete et Cou | 2000-03-01 |
| Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC (NCT00162708) | Gustave Roussy, Cancer Campus, Grand Paris | 1996-07-01 |
| Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer (NCT00080028) | Pharmacyclics LLC. | |